The goal of this study was to assess the scale of low-level parental mosaicism in exome sequencing (ES) databases.
We analyzed approximately 2000 family trio ES data sets from the Baylor-Hopkins Center for Mendelian Genomics (BHCMG) and Baylor Genetics (BG). Among apparent de novo single-nucleotide variants identified in the affected probands, we selected rare unique variants with variant allele fraction (VAF) between 30% and 70% in the probands and lower than 10% in one of the parents.
Of 102 candidate mosaic variants validated using amplicon-based next-generation sequencing, droplet digital polymerase chain reaction, or blocker displacement amplification, 27 (26.4%) were confirmed to be low- (VAF between 1% and 10%) or very low (VAF <1%) level mosaic. Detection precision in parental samples with two or more alternate reads was 63.6% (BHCMG) and 43.6% (BG). In nine investigated individuals, we observed variability of mosaic ratios among blood, saliva, fibroblast, buccal, hair, and urine samples.
Our computational pipeline enables robust discrimination between true and false positive candidate mosaic variants and efficient detection of low-level mosaicism in ES samples. We confirm that the presence of two or more alternate reads in the parental sample is a reliable predictor of low-level parental somatic mosaicism.
Subscribe to Journal
Get full journal access for 1 year
only $94.83 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
The source code of our filtering pipeline is publicly available at https://github.com/tgambin/LowLevelMosaicVariantCaller.
Biesecker LG, Spinner NB. A genomic view of mosaicism and human disease. Nat Rev Genet. 2013;14:307–320.
Boone PM, Bacino CA, Shaw CA, et al. Detection of clinically relevant exonic copy-number changes by array CGH. Hum Mutat. 2010;31:1326–1342.
Bartnik M, Derwińska K, Gos M, et al. Early-onset seizures due to mosaic exonic deletions of CDKL5 in a male and two females. Genet Med. 2011;13:447–452.
Poduri A, Evrony GD, Cai X, Walsh CA. Somatic mutation, genomic variation, and neurological disease. Science. 2013;341:1237758.
Ansari M, Poke G, Ferry Q, et al. Genetic heterogeneity in Cornelia de Lange syndrome (CdLS) and CdLS-like phenotypes with observed and predicted levels of mosaicism. J Med Genet. 2014;51:659–668.
Stosser MB, Lindy AS, Butler E, et al. High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders. Genet Med. 2018;20:403–410.
Krupp DR, Barnard RA, Duffourd Y, et al. Exonic mosaic mutations contribute risk for autism spectrum disorder. Am J Hum Genet. 2017;101:369–390. https://doi.org/10.1016/j.ajhg.2017.07.016
Lim ET, Uddin M, De Rubeis S, et al. Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder. Nat Neurosci. 2017;20:1217–1224.
Lupski JR. Genetics. Genome mosaicism-one human, multiple genomes. Science. 2013;341:358–359.
Acuna-Hidalgo R, Bo T, Kwint MP, et al. Post-zygotic point mutations are an underrecognized source of de novo genomic variation. Am J Hum Genet. 2015;97:67–74.
Halvorsen M, Petrovski S, Shellhaas R, et al. Mosaic mutations in early-onset genetic diseases. Genet Med. 2016;18:746–749.
Campbell IM, Shaw CA, Stankiewicz P, Lupski JR. Somatic mosaicism: implications for disease and transmission genetics. Trends Genet. 2015;31:382–392.
Goldmann JM, Veltman JA, Gilissen C. De novo mutations reflect development and aging of the human germline. Trends Genet. 2019;35:828–839.
Møller RS, Liebmann N, Larsen LHG, et al. Parental mosaicism in epilepsies due to alleged de novo variants. Epilepsia. 2019;60:e63–e66.
Wright CF, Prigmore E, Rajan D, et al. Clinically-relevant postzygotic mosaicism in parents and children with developmental disorders in trio exome sequencing data. Nat Commun. 2019;10:2985. https://doi.org/10.1038/s41467-019-11059-2
Cao Y, Tokita MJ, Chen ES, et al. A clinical survey of mosaic single nucleotide variants in disease-causing genes detected by exome sequencing. Genome Med. 2019;11:48
Campbell IM, Yuan B, Robberecht C, et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am J Hum Genet. 2014;95:173–182.
Liu Q, Karolak JA, Grochowski CM, et al. Parental somatic mosaicism for CNV deletions—a need for more sensitive and precise detection methods in clinical diagnostics settings. Genomics. 2020;112:2937–2941. https://doi.org/10.1016/j.ygeno.2020.05.003
Liu Q, Grochowski CM, Bi W, Lupski JR, Stankiewicz P. Quantitative assessment of parental somatic mosaicism for copy-number variant (CNV) deletions. Curr Protoc Hum Genet. 2020;106:e99.
Rahbari R, Wuster A, Lindsay SJ, et al. Timing, rates and spectra of human germline mutation. Nat Genet. 2016;48:126–133.
Jónsson H, Sulem P, Arnadottir GA, et al. Multiple transmissions of de novo mutations in families. Nat Genet. 2018;50:1674–1680.
Campbell IM, Stewart JR, James RA, et al. Parent of origin, mosaicism, and recurrence risk: probabilistic modeling explains the broken symmetry of transmission genetics. Am J Hum Genet. 2014;95:345–359.
Breuss MW, Antaki D, George RD, et al. Autism risk in offspring can be assessed through quantification of male sperm mosaicism. Nat Med. 2020;26:143–150.
Gambin T, Jhangiani SN, Below JE, et al. Secondary findings and carrier test frequencies in a large multiethnic sample. Genome Med. 2015;7:54
Reid JG, Carroll A, Veeraraghavan N, et al. Launching genomics into the cloud: deployment of Mercury, a next generation sequence analysis pipeline. BMC Bioinformatics. 2014;15:30.
McLaren W, Gil L, Hunt SE, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122.
Challis D, Yu J, Evani US, et al. An integrative variant analysis suite for whole exome next-generation sequencing data. BMC Bioinformatics. 2012;13:8.
Bailey JA, Gu Z, Clark RA, et al. Recent segmental duplications in the human genome. Science. 2002;297:1003–1007.
Zastrow DB, Zornio PA, Dries A, et al. Exome sequencing identifies de novo pathogenic variants in FBN1 and TRPS1 in a patient with a complex connective tissue phenotype. Cold Spring Harb Mol Case Stud. 2017;3:a001388.
Robinson JT, Thorvaldsdóttir H, Winckler W, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–26.
Wu LR, Chen SX, Wu Y, Patel AA, Zhang DY. Multiplexed enrichment of rare DNA variants via sequence-selective and temperature-robust amplification. Nat Biomed Eng. 2017;1:714–723.
Fiévet A, Bernard V, Tenreiro H, et al. ART-DeCo: easy tool for detection and characterization of cross-contamination of DNA samples in diagnostic next-generation sequencing analysis. Eur J Hum Genet. 2019;27:792–800.
Ma X, Shao Y, Tian L, et al. Analysis of error profiles in deep next-generation sequencing data. Genome Biol. 2019;20:50.
Salk JJ, Schmitt MW, Loeb LA. Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nat Rev Genet. 2018;19:269–285.
Kim J, Kim D, Lim JS, et al. The use of technical replication for detection of low-level somatic mutations in next-generation sequencing. Nat Commun. 2019;10:1–11.
Costello M, Fleharty M, Abreu J, et al. Characterization and remediation of sample index swaps by non-redundant dual indexing on massively parallel sequencing platforms. BMC Genomics. 2018;19:332.
Yang X, Liu A, Xu X. et al. Genomic mosaicism in paternal sperm and multiple parental tissues in a Dravet syndrome cohort. Sci Rep. 2017;7:15677.
Shlush LI. Age-related clonal hematopoiesis. Blood. 2018;131:496–504.
Karolak JA, Liu Q, Xie NG, et al. Highly sensitive blocker displacement amplification and droplet digital PCR reveal low-level parental FOXF1 somatic mosaicism in families with alveolar capillary dysplasia with misalignment of pulmonary veins. J Mol Diagn. 2020;22:447–456.
We are thankful to our colleagues who provided their expertise that greatly assisted this research work. We thank Davut Pehlivan for helpful discussion. This study is supported by the US National Institute of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) grant R01HD087292 to P.S., National Human Genome Research Institute (NHGRI)/National Heart, Lung, and Blood Institute (NHLBI) grant UM1HG006542 to the Baylor-Hopkins Center for Mendelian Genomics (BHCMG), and NHGRI grant HG008986 to J.E.P.
The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from clinical exome sequencing offered by the Baylor Genetics Laboratories. Authors who are faculty members in the Department of Molecular and Human Genetics at Baylor College of Medicine are identified as such in the affiliation section. J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, and is a coinventor on multiple US and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. D.Y.Z. and L.R.W. have a patent pending on blocker displacement amplification. D.Y.Z., N.G.X., and L.R.W. are consultants of NuProbe Global. D.Y.Z. consults for Avenge Bio. D.Y.Z. owns equity of NuProbe Global and Torus Biosystems. The other authors declare no conflicts of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Gambin, T., Liu, Q., Karolak, J.A. et al. Low-level parental somatic mosaic SNVs in exomes from a large cohort of trios with diverse suspected Mendelian conditions. Genet Med (2020). https://doi.org/10.1038/s41436-020-0897-z
- exome sequencing
- parental somatic mosaicism
- rare variants
- Mendelian genomics